The National Center for Complementary and Integrative Health (NCCIH), the primary federal agency spearheading research on integrative health, has awarded a five-year, $1.8 million grant to study the effectiveness of shan zhu yu (Fructus corni / Cornus officinalis) in treating type 1 diabetes.
TCM practitioners / researchers Dr. Clare Zhang and Dr. John Chen are members of the research team conducting the study – a multi-institution endeavor led by Dr. Brant Burkhardt from the University of South Florida Department of Molecular Biosciences (co-principal investigator); Dr. Stanley Stevens Jr. and PhD candidate Justin Fletcher (co-principal investigator) from the USF Department of Molecular Biosciences; and Dr. Mark Atkinson from the Department of Pathology and Pediatrics at the University of Florida.
“Our NCCIH proposal aims to explain the mechanism of action, determine effect on T1D onset and progression in-vivo, and reveal the precise biological agents within Cornus officinalis,” said Dr. Burkhardt in a USF press release announcing the grant award. “We hope this study will provide new insights into the clinical use ... and reveal what is needed for pancreatic B-cell survival and function to provide a well-tolerated therapy for early onset T1D.”
According to Dr. Chen, “Traditionally, Shan Zhu Yu (Fructus corni), commonly known as Asiatic Dogwood, is classified as an astringent herb that also has significant effect to nourish Liver and Kidney yin to treat various disorders characterized by weakness, atrophy, debility, deterioration and loss of body fluids. More recently, it has been explored to treat diabetes and the associated complications. It also has an excellent anti-inflammatory effect to counter the long-term adverse effects of inflammatory diseases.”
More than 350,000 U.S. children and adolescents under the age of 20 live with diagnosed type 1 diabetes, which manifests when the body’s immune system attacks and destroys pancreatic beta cells, which are responsible for producing insulin. Per Dr. Burkhardt, “Despite strong predictive biomarkers of T1D, there is no cure and only one recently approved interventional therapy to slow disease progression,” underscoring the importance of this research.
Do you receive text messages from companies letting you know about offers or giveaways, or simply sharing news? If your answer is yes, then you have opted in for SMS (short message service) text-message marketing. SMS text-message marketing uses various platforms and software to send personalized, timely and sometimes interactive messages.
The Oregon College of Oriental Medicine (OCOM) has announced it is closing after 41 years. Pending accreditor approval, OCOM will cease offering classes after September (fourth-year OCOM students graduate Aug. 26). All current / incoming OCOM students have the option of continuing their education at the National University of Natural Medicine or Five Branches University, or transferring to another school altogether.
| Digital Exclusive
The end of cancer treatment does not necessarily signal a return to good health. Cancer survivors report poorer health and well-being than people who have not had cancer; many suffer chronic consequences of cancer and its treatments. Some may also develop new symptoms many years after treatment has ended.
